Millicent Sullivan

Millicent Sullivan is the Alvin B. and Julie O. Stiles Professor of Chemical & Biomolecular Engineering and Professor of Biomedical Engineering at the University of Delaware. She is affiliated with the Allan P. Colburn Laboratory and focuses on developing biomaterials and nanocarriers for nucleic acid and drug delivery in regenerative medicine. Her research addresses challenges in gene therapy, siRNA delivery, and targeted drug delivery for cancers and tissue repair.

Dr. Sullivan holds a Ph.D. in Chemical Engineering from Carnegie Mellon University and a B.S. in Chemical Engineering from Princeton University.

Her research interests include engineering polymer and peptide-based nanocarriers to target intracellular organelles, exploring stimuli-responsive materials for controlled drug release, and integrating growth factor delivery with wound repair mechanisms. She also investigates bioinspired systems like collagen-mimetic peptides and viral-like particles for therapeutic applications.

Recent work highlights advancements in light-responsive nanocarriers, HBV protein particles for targeted delivery, and ECM turnover-stimulated gene transfer. Her lab’s innovations aim to enhance therapeutic efficacy while minimizing side effects in conditions like cancer and chronic wounds.

Collaborations focus on interdisciplinary approaches combining chemical engineering, biomaterials science, and cell biology. Her lab’s website provides further details on ongoing projects and clinical translation efforts.